Tackling the misuse of patents by some big pharma companies could go a long way to bringing down drug prices.
Some pharmaceutical companies are gaming the patent system to extend their monopoly, keeping prices high for patients.
Amelie-Benoist / AFP
The misuse of patents by some of the world’s biggest pharma companies to stifle competition is rarely discussed in global drug-pricing debates. Yet rectifying this problem could help to lower drug prices for patients everywhere, explains healthcare reporter Jessica Davis Plüss.
Generated with artificial intelligence.
This content was published on
U.S. pricing has been the bigegts issue of the year for drugmakers heavily exposed to the U.S. market.
Big pharma is grappling with new drug pricing deals and roughly $300 billion in potential lost revenue from patent expirations of…
Americans are not paying high prices because of other western countries. Pharmaceutical companies are to blame
Companies are facing a situation where they need to fill their pipelines, but also navigate a competitive environment for the…
President Donald Trump has pushed to lower drug prices for Americans, which are on average nearly three times higher than…
TRIBUNE. Le système de négociation international entre laboratoires et Etats risque d’être bouleversé par les Etats-Unis. Dans…
